Vanda Pharmaceuticals Inc. (VNDA) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I…
Source: Yahoo Finance
Sector & Industry
Vanda Pharmaceuticals Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Vanda Pharmaceuticals Inc. at a Glance
| Company | Vanda Pharmaceuticals Inc. |
| Ticker | VNDA |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $5.43 |
| Market cap | $328.31M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$4.64 |
| 52-week high | $9.94 |
| 52-week low | $4.27 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.65 |
| Return on equity (ROE) | -77.81% |
| Debt-to-equity | 10.37% |
| Average volume | 913,492 |
| Shares outstanding | 60.46M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 533 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Vanda Pharmaceuticals Inc.'s current P/E ratio?
- Vanda Pharmaceuticals Inc. (VNDA) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Vanda Pharmaceuticals Inc.'s market capitalisation?
- Vanda Pharmaceuticals Inc.'s market cap is $328.31M based on our latest snapshot. See how it ranks by market cap →
- What is VNDA's 52-week range?
- Over the past 52 weeks, VNDA has traded between $4.27 and $9.94. What does the 52-week range mean? →
- How volatile is Vanda Pharmaceuticals Inc. compared to the market?
- Vanda Pharmaceuticals Inc. has a beta of 0.65, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Vanda Pharmaceuticals Inc. pay a dividend?
- Vanda Pharmaceuticals Inc. does not currently pay a dividend according to our latest data.
- What exchange is VNDA listed on?
- VNDA is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Vanda Pharmaceuticals Inc. in?
- Vanda Pharmaceuticals Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →